Evidence map›Paper›PMID 30022438›Full record

ArticleJournal of molecular neuroscience : MN2019

PACAP38-Mediated Bladder Afferent Nerve Activity Hyperexcitability and Ca

Thomas J Heppner, Grant W Hennig, Mark T Nelson, Victor May, Margaret A Vizzard

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular neuroscience : MN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Protective Effects of PACAP in Peripheral Organs.Frontiers in endocrinology · 2020
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Thomas J HeppnerDepartment of Pharmacology, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05405, USA.
Grant W HennigDepartment of Pharmacology, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05405, USA.
Mark T NelsonDepartment of Pharmacology, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05405, USA.
Victor MayDepartment of Pharmacology, The Robert Larner, M.D. College of Medicine at The University of Vermont, Burlington, VT, 05405, USA.
Margaret A VizzardDepartment of Neurological Sciences, The Robert Larner, M.D. College of Medicine at The University of Vermont, Given Building, D405A, Burlington, VT, 05405, USA. Margaret.Vizzard@uvm.edu.ORCID http://orcid.org/0000-0002-8360-8614
University of Vermont · US

Funding

Cystitis-Induced Plasticity of Micturition ReflexesR01DK051369 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 2003 to 2017
$5.4M
Developmental Plasticity of Micturition ReflexesR01DK060481 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 2002 to 2018
$4.5M
Center for Neuroscience ExcellenceP30GM103498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 2012 to 2015
$4.3M
Ca2+ Sparks and Urinary Bladder Smooth Muscle ExcitabilityR37DK053832 · NIDDK · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI NELSON, MARK T · 2008 to 2017
$3.4M
CENTER FOR NEUROSCIENCE EXCELLENCEP30RR032135 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI PARSONS, RODNEY L · 2011 to 2011
$1.1M
IRRITATION INDUCED PLASTICITY OF MICTURITION PATHWAYSR29DK051369 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VIZZARD, MARGARET ANN · 1996 to 2000
$109k
National Institute of Diabetes and Digestive and Kidney Diseases R37-DK053832National Institute of Diabetes and Digestive and Kidney Diseases RO1-DK051369National Institute of Diabetes and Digestive and Kidney Diseases RO1-DK060481NCRR NIH HHS P30 RR032135NIDDK NIH HHS R01 DK051369NIDDK NIH HHS R01 DK060481NIDDK NIH HHS R29 DK051369NIDDK NIH HHS R37 DK053832NIGMS NIH HHS P30 GM103498
6 · The paper itself

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP; Adcyap1) and its cognate PAC1 receptor (Adcyap1r1) have tissue-specific distributions in the lower urinary tract (LUT). The afferent limb of the micturition reflex is often compromised following bladder injury, disease, and inflammatory conditions. We have previously demonstrated that PACAP signaling contributes to increased voiding frequency and decreased bladder capacity with cystitis. Thus, the present studies investigated the sensory components (e.g., urothelial cells, bladder afferent nerves) of the urinary bladder that may underlie the pathophysiology of aberrant PACAP activation. We utilized bladder-pelvic nerve preparations and urothelial sheet preparations to characterize PACAP-induced bladder afferent nerve discharge with distention and PACAP-induced Ca

Indexed as

Action PotentialsAnimalsCalciumMaleMiceMice, Inbred C57BLNeurons, AfferentPituitary Adenylate Cyclase-Activating PolypeptideSignal TransductionUrotheliumCalciumPituitary Adenylate Cyclase-Activating PolypeptideMicturitionNerve activityNeuropeptidesUrinary bladder distension

Identifiers

PMID30022438
PMCPMC6339595
OpenAlexW2883877097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.